PCSK9 and hemorrhagic stroke: Another systematic review showed that statins increased the risk of hemorrhagic stroke (RR: 1.15, 95% CI: 1.00-1.32), but PCSK9 inhibitors did not increase the risk (RR: 0.93, 95% CI: 0.58-1.51) [40].